The Clorox Company $CLX Shares Sold by First National Bank of Mount Dora Trust Investment Services

First National Bank of Mount Dora Trust Investment Services trimmed its holdings in The Clorox Company (NYSE:CLX) by 9.1% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,246 shares of the company’s stock after selling 224 shares during the period. First National Bank of Mount Dora Trust Investment Services’ holdings in Clorox were worth $270,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Sumitomo Mitsui DS Asset Management Company Ltd lifted its stake in shares of Clorox by 0.6% in the 1st quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,266 shares of the company’s stock valued at $1,953,000 after purchasing an additional 73 shares in the last quarter. Horizon Investments LLC lifted its position in Clorox by 4.4% during the 1st quarter. Horizon Investments LLC now owns 1,768 shares of the company’s stock worth $258,000 after acquiring an additional 75 shares in the last quarter. Sfmg LLC lifted its position in Clorox by 2.8% during the 1st quarter. Sfmg LLC now owns 2,780 shares of the company’s stock worth $409,000 after acquiring an additional 76 shares in the last quarter. Hancock Whitney Corp lifted its position in Clorox by 4.3% during the 1st quarter. Hancock Whitney Corp now owns 2,064 shares of the company’s stock worth $304,000 after acquiring an additional 86 shares in the last quarter. Finally, American National Bank & Trust lifted its position in Clorox by 69.5% during the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after acquiring an additional 89 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares in the company, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.63% of the company’s stock.

Clorox Price Performance

CLX stock opened at $117.66 on Friday. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The Clorox Company has a 52-week low of $116.53 and a 52-week high of $171.37. The stock’s 50 day moving average is $121.71 and its two-hundred day moving average is $128.06. The company has a market capitalization of $14.33 billion, a PE ratio of 18.05, a P/E/G ratio of 0.98 and a beta of 0.52.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. During the same period in the previous year, the business earned $1.82 EPS. Clorox’s revenue for the quarter was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be issued a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.2%. The ex-dividend date is Wednesday, October 22nd. Clorox’s payout ratio is 76.07%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on CLX. Deutsche Bank Aktiengesellschaft reduced their price target on Clorox from $135.00 to $128.00 and set a “hold” rating on the stock in a research report on Monday. Wells Fargo & Company reduced their price target on Clorox from $130.00 to $125.00 and set an “equal weight” rating on the stock in a research report on Thursday, September 25th. Zacks Research raised Clorox from a “strong sell” rating to a “hold” rating in a research report on Monday, September 29th. TD Cowen reduced their price target on Clorox from $120.00 to $117.00 and set a “hold” rating on the stock in a research report on Wednesday, October 1st. Finally, Bank of America reduced their price target on Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. One analyst has rated the stock with a Buy rating, twelve have given a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, Clorox has a consensus rating of “Reduce” and an average target price of $131.64.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.